The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
about
Administration of Extended Infusion Piperacillin-TazobactamWith the Use of Smart Pump Technology.Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis.Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious DiseasesEmpiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearanceGuidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial.Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections.Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship.Using higher doses to compensate for tubing residuals in extended-infusion piperacillin-tazobactam.Pseudomonas aeruginosa treatment and transmission reduction.Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis.Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance.Extended Infusion of Piperacillin/Tazobactam in Children.Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model.Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia.Clinical Outcomes of Extended Versus Intermittent Infusion of Piperacillin/Tazobactam in Critically Ill Patients: A Prospective Clinical Trial.Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art.Hospital Length of Stay Among Patients Receiving Intermittent Versus Prolonged Piperacillin/Tazobactam Infusion in the Intensive Care Units.Evaluation of an alternative extended-infusion piperacillin-tazobactam dosing strategy for the treatment of gram-negative infections.Targeted benefits of prolonged-infusion piperacillin-tazobactam in an in vitro infection model of Pseudomonas aeruginosa.Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy.Extended infusion versus intermittent infusion of imipenem in the treatment of ventilator-associated pneumonia.Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam.Saving lives with optimal antimicrobial chemotherapy.Investigation on outcomes and bacterial distributions of liver cirrhosis patients with gram-negative bacterial bloodstream infection.
P2860
Q33774704-AD8396FB-2CC7-4187-8B59-39673CED3D7DQ34058137-21C623A6-9FA6-4FAE-BA65-765D8E4032B5Q34892334-6D3447D8-3F74-46CD-9F2E-4FE2A6DBC5D4Q35986250-0B0FA19C-FF38-48B3-AD93-30EBE1224A1AQ36089167-268DB038-C10D-406F-AE20-9F78C4D1003DQ36281234-8F76DA58-1EA5-4A7F-BE13-C7B9C8728057Q36439015-C1BF8E27-EA78-4E9C-A1F7-ABA039A1C062Q36633761-DF78CDF2-823A-4223-A486-B2A2F8015E4EQ36969880-A188D984-E861-44AF-A1D5-CF1E7A86626FQ37335840-8E1E9468-D7C0-4EB9-99F2-E1A7EC660733Q38073197-BCAA3B11-68A7-4468-8008-9A732FD3FE02Q38110142-CE491F01-7E43-4696-A391-DB9DD5DB2F6FQ38131538-7C57EC90-0A84-4990-8FC6-5C1F116C250CQ38167345-9A10FC47-5ADF-446A-8577-E29909D3E1AEQ38705266-7CE5F5DB-A978-457B-9E1F-4D3903A5ADF2Q38714853-2A726A64-3261-4F5D-B58E-8F6C76AD1808Q38896040-E2F3155F-B9F7-458B-89D1-6E995B8E8C2FQ39516974-C50C0B8E-3EBA-4F98-9F0B-196ADD953EBBQ40073466-2A5BBAD5-FCF0-4337-8DE3-2EA948164656Q40078698-B0BC8EB8-EA9E-4403-8C21-AC9EFFEC3DADQ40087256-2D885183-3EB4-45DF-BD90-C1E2B2BB9047Q40095692-81F02845-1742-4A8A-9CB8-365D71360A44Q40219976-A4840D9C-894A-43C8-B793-E9CC6EE01C3FQ40687385-D502B6B7-4639-4F45-BE33-12B3F7FFDF12Q40714798-2D931AEE-6F9D-4B91-96DC-ED64B7F58838Q41148311-68A95A64-A1C2-46AB-950F-FEA0680A4E6CQ41354782-7E25EB30-538B-4B55-BE29-0F27358FA712Q42062112-64627A06-B6FE-4DAF-AC9E-34C80C5384C6Q44358114-686A70F5-983C-45EE-9E44-C4A06BDD8ED4Q49171086-59D2A7D0-9F6F-45FF-B062-9D3139143A6F
P2860
The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The Retrospective Cohort of Ex ...... T) study: a multicenter study.
@en
The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam
@nl
type
label
The Retrospective Cohort of Ex ...... T) study: a multicenter study.
@en
The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam
@nl
prefLabel
The Retrospective Cohort of Ex ...... T) study: a multicenter study.
@en
The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam
@nl
P2860
P356
P1433
P1476
The Retrospective Cohort of Ex ...... PT) study: a multicenter study
@en
P2093
Diane M Cappelletty
RECEIPT Study group
P2860
P304
P356
10.1592/PHCO.31.8.767
P407
P577
2011-08-01T00:00:00Z